Illumina Inc at Bank of America Merrill Lynch Health Care Conference Transcript
Thanks for joining us. My name is Mike Ryskin, I'm on the life science tools and diagnostics team here at Bank of America Merrill Lynch. I'm here on behalf of the senior analyst De Bruin, who unfortunately couldn't be here with us today but he sends his regards and he's following along via the webcast.
Joining us for the next session is Illumina, and here we're joined by Sam Samad. I think we'll start with about 20, 25 minutes of fireside chat and then we'll open up to the audience for Q&A. So I think there's a initial statement you got to give.
Yes, the fun part. So thanks, Mike, first of all, for inviting us and pleasure to be here. Good morning, everybody. So I've been asked to remind you that my comments today could include forward-looking statements. You should refer to our SEC filings for a discussion of the risks and uncertainties that could cause results to differ materially from our current expectations. It is
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
